Chemo-Immunotherapy Combination Of Idelalisib With Bendamustine/Rituximab Or Chlorambucil/Rituximab In Patients With Relapsed/Refractory CLL Demonstrates Efficacy and Tolerability
暂无分享,去创建一个
J. Leonard | I. Flinn | K. Rai | S. Coutre | R. Furman | Yeonhee Kim | N. Wagner-Johnston | J. Sharman | J. Barrientos | M. Schreeder | S. Vos | L. Holes | R. Dansey | H. Adewoye | Leanne Holes